Research Papers

17 of 2317 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Biomarkers of HIV Susceptibility and Disease Progression.
Pirrone V; Mell J; Janto B; Wigdahl B.
EBioMedicine (Unknown)
Published: 2014
1/6 Transparent
Dangerous Membranes: Viruses That Subvert Autophagosomes.
Jackson WT.
EBioMedicine (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Key Challenges in Rheumatic and Musculoskeletal Disease Translational Research.
Fearon U; Veale DJ.
EBioMedicine (Unknown)
Published: 2014
1/6 Transparent
Stem Cell-Derived Beta Cells for Treatment of Type 1 Diabetes?
Goland R; Egli D.
EBioMedicine (Unknown)
Published: 2014
2014: A Year of Breakthroughs for Translational Science.
EBioMedicine.
EBioMedicine (Unknown)
Published: 2014
In Vivo Application of Tissue-Engineered Veins Using Autologous Peripheral Whole Blood: A Proof of Concept Study.
Olausson M; Kuna VK; Travnikova G; Bäckdahl H; Patil PB; Saalman R; Borg H; Jeppsson A; Sumitran-Holgersson S.
EBioMedicine (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Development of a Tissue-Engineering Vascular Graft for Use in Congenital Heart Surgery.
Shinoka T.
EBioMedicine (Unknown)
Published: 2014
1/6 Transparent
Assessing Cellular Responses in Sepsis.
Vincent JL.
EBioMedicine (Unknown)
Published: 2014
1/6 Transparent
α(+)Thalassemia Antagonizes the Malaria-protective Effects of Sickle-Cell Trait.
Amaratunga C; Fairhurst RM.
EBioMedicine (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Ebola Conquers West Africa - More to Come?
Halfmann P; Neumann G; Feldmann H; Kawaoka Y.
EBioMedicine (Unknown)
Published: 2014
1/6 Transparent
Funding Declared
EBioMedicine: Bridging Two Cultures to Improve Health.
NA
EBioMedicine (Unknown)
Published: 2014
Mechanistic Studies of the Negative Epistatic Malaria-protective Interaction Between Sickle Cell Trait and α<sup>+</sup…
Opi DH; Ochola LB; Tendwa M; Siddondo BR; Ocholla H; Fanjo H; Ghumra A; Ferguson DJ; Rowe JA; Williams TN.
EBioMedicine (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
An Endotoxin Tolerance Signature Predicts Sepsis and Organ Dysfunction at Initial Clinical Presentation.
Pena OM; Hancock DG; Lyle NH; Linder A; Russell JA; Xia J; Fjell CD; Boyd JH; Hancock RE.
EBioMedicine (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Diversity and composition of the adult fecal microbiome associated with history of cesarean birth or appendectomy: Anal…
Goedert JJ; Hua X; Yu G; Shi J.
EBioMedicine (Unknown)
Published: 2014
3/6 Transparent
Code Funding Declared
A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignancies.
Uckun FM; Qazi S; Ma H; Yin L; Cheng J.
EBioMedicine (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infect…
Zolla-Pazner S; Edlefsen PT; Rolland M; Kong XP; deCamp A; Gottardo R; Williams C; Tovanabutra S; Sharpe-Cohen S; Mullins JI; deSouza MS; Karasavvas N; Nitayaphan S; Rerks-Ngarm S; Pitisuttihum P; Kaewkungwal J; O'Connell RJ; Robb ML; Michael NL; Kim JH; Gilbert P.
EBioMedicine (Unknown)
Published: 2014
3/6 Transparent
Registered Funding Declared
A PREVIOUSLY UNKNOWN UNIQUE CHALLENGE FOR INHIBITORS OF SYK ATP-BINDING SITE: ROLE OF SYK AS A CELL CYCLE CHECKPOINT RE…
Uckun FM; Ma H; Ozer Z; Goodman P; Zhang J; Qazi S.
EBioMedicine (Unknown)
Published: 2014
2/6 Transparent
Funding Declared